Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

A Review of COVID-19 Vaccines: What Needs to Be Known and Its Expected Effect on the Human Population?

Version 1 : Received: 17 April 2021 / Approved: 19 April 2021 / Online: 19 April 2021 (12:04:31 CEST)

How to cite: Tuba, S.; Widyati, W.; Syed Sulaiman, S.A. A Review of COVID-19 Vaccines: What Needs to Be Known and Its Expected Effect on the Human Population?. Preprints 2021, 2021040468 (doi: 10.20944/preprints202104.0468.v1). Tuba, S.; Widyati, W.; Syed Sulaiman, S.A. A Review of COVID-19 Vaccines: What Needs to Be Known and Its Expected Effect on the Human Population?. Preprints 2021, 2021040468 (doi: 10.20944/preprints202104.0468.v1).

Abstract

The COVID-19 pandemic is a devastating blow to the entire world community and changes the order of human life. All efforts and strategies are being carried out to contain and reduce the spread of the SARS-COV-2 virus, both by tightening the health protocol and using vaccines to the public. Currently, several vaccines are available and have passed phase 3 clinical trials, such as vector vaccines (Gamaleya Sputnik V Russia, University of Oxford/AstraZeneca, CanSino, and Janssen Pharmaceutical Companies), mRNA-based vaccines (Moderna/BioNTech/Fosun Pharma/Pfizer), inactivated vaccines (SinoVac and SinoPharm from China, Covaxin from Bharat Biotech India), and adjuvanted recombinant protein nanoparticles (Novavax from the USA) are expected to be able to suppress the spread of the virus and produce a minimum of 70 percent herd-immunity in a population. Each vaccine's efficacy varies from the lowest, namely the Sinovac vaccine (CoronaVac) 50% to the highest the Novavax vaccine (NVX-Cov2373) 96% effectivity value. Moreover, further rigorous research is still being carried out for the development of an effective and efficient vaccine.

Keywords

Vaccine Development; Clinical Trial; COVID-19; SARS-COV-2

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.